
Loading, please wait...

Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
— Hippocrates

Researchers are revolutionizing hepatology through **PRM proteomics liver research** to improve organelle validation. Mitochondria regulate metabolic processes, and their dysfunction marks liver diseases like steatosis and hepatectomy-induced failure. Consequently, clinicians require pure mitochondrial isolations for reliable proteomic analysis. While researchers commonly use subcellular fractionation, they often face challenges with fraction purity. Traditional methods like immunoblotting offer limited sensitivity and suffer from high variability. Therefore, a more robust quantitative approach is necessary for translational studies.
A recent study introduces parallel reaction monitoring (PRM) as a highly sensitive alternative to western blotting. This targeted mass spectrometry strategy quantitatively assesses the enrichment of cytosolic, mitochondrial, and nuclear fractions. Specifically, the study evaluated mouse liver tissue and PLC/PRF/5 cells using commercial isolation kits. Moreover, PRM demonstrated specific enrichment across different biological systems. These results suggest that PRM provides a cost-effective and reproducible solution for laboratory workflows.
The analysis showed significant mitochondrial enrichment for markers such as ATPase. Furthermore, Prelamin A/C displayed high nuclear-to-cytosolic ratios in cellular models. Additionally, cytosolic markers consistently appeared in their respective fractions. Because PRM captures full fragment ion spectra, it ensures high specificity and quantitative accuracy. Thus, this methodology supports high-quality mitochondrial preparations for studying liver physiology. Researchers can now replace restricted immunodetection methods with this sensitive proteomic tool.
PRM offers higher sensitivity, reproducibility, and throughput. Unlike Western blotting, it provides absolute quantification and reduces experimental variability across different biological systems.
Contamination from other organelles can skew metabolic and proteomic results. Accurate validation ensures that the observed effects are truly mitochondrial, which is vital for studying steatosis and liver failure.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare providers with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Delgado-Sequera A et al. Targeted Quantitative Analysis of Specific Proteins in Cytosolic, Mitochondrial, and Nuclear Fractions Using PRM. J Proteome Res. 2026 Feb 25. doi: 10.1021/acs.jproteome.5c00697. PMID: 41740191.
Peterson AC, Russell JD, Bailey DJ, Westphall MS, Coon JJ. Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics. Mol Cell Proteomics. 2012 Nov;11(11):1475-88. doi: 10.1074/mcp.O112.020131.
Vidova V, Spacil Z. A review on parallel reaction monitoring: a powerful method for targeted proteomics. BioMolecular Concepts. 2017;8(3-4):145-154. doi: 10.1515/bmc-2017-0014.

A new study shows that PRM proteomics outperforms traditional immunoblotting for validating the purity of subcellular liver fractions....
3 months ago

A Sardinia-based study reveals a Behçet's syndrome prevalence of 11.7 per 100,000, highlighting the value of combining administrative and clinical data....
Today

A systematic review identifies the BNIP3→mtROS→NLRP1 axis as a central driver of placental injury and the inflammatory phenotype in preeclampsia....
Today

A large individual patient data meta-analysis identifies 4.0-5.0 mmol/L as the optimal serum potassium range for both HFrEF and HFpEF patients....
Today

Innovative MOF-polymer composites now offer self-healing and sense-healing capabilities for robust soft robotics and wearable electronics....
Today

A study explores how pharmacist-led initiatives at health centers improve access to CGM technology for patients with uncontrolled type 2 diabetes....
Today